Long Term Vascular Changes in Type 1 Diabetes (DM09)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00991575|
Recruitment Status : Unknown
Verified October 2009 by Oslo University Hospital.
Recruitment status was: Enrolling by invitation
First Posted : October 8, 2009
Last Update Posted : October 8, 2009
|Condition or disease|
|Diabetes Mellitus, Type 1 Complications Coronary Heart Disease|
Despite intensively research in the field of hyperglycaemia and coronary heart disease in type 1 diabetes it is still not known in detail how hyperglycaemia leads to damage of the vessels.
The aims of the present proposal are therefore two-fold:
- To study in detail the progression of atherosclerosis (and micro vascular complications) in a well characterized cohort of type 1 diabetes with a long duration of the disease. This project will be a continuation of the Oslo study, a cohort started in 1982, with the last follow-up study in 1999/2000.
- To define factors responsible for the progression of coronary heart disease (and micro vascular complications) in this cohort.
|Study Type :||Observational|
|Estimated Enrollment :||45 participants|
|Official Title:||Long Term Vascular Changes in Type 1 Diabetes, Clinical Aspects and Biological Markers|
|Study Start Date :||April 2009|
|Estimated Primary Completion Date :||April 2010|
|Estimated Study Completion Date :||May 2010|
|Diabetes, type 1|
- Fatal and non fatal cardiovascular disease (CVD) and stroke [ Time Frame: One year ]
- Vessel area stenosis [ Time Frame: One year ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00991575
|Oslo University hospital, Aker|
|Oslo, Norway, 0514|
|Principal Investigator:||Kristian F Hanssen, Professor MD||Oslo university hospital, Aker, Norway|